While current clinical trials for cardiac regeneration using induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) ...
When celebrities talk about a health condition or medical treatment, it garners attention. The same thing happened when ...
Longeveron receives Japanese patent for potency assay methods to assess human mesenchymal stem cells: Miami Saturday, January 31, 2026, 13:00 Hrs [IST] Longeveron Inc, a clinical ...
Patients with weak heart function who receive stem cell therapy shortly after a heart attack are at lower risk of developing heart failure and related hospital stays compared with standard care, finds ...